Technical Data
A3596-02
AADAC, CT (Arylacetamide Deacetylase, DAC)
Description:
Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens.

Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:50-1:100
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGPurified
SizeStorageShippingSourceHost
200ul-20°CBlue IceHumanRabbit
Concentration:
~0.25mg/ml
Immunogen:
KLH-conjugated synthetic peptide corresponding to a portion of amino acids within residues 279-309 in the C-terminal region of human AADAC.
Purity:
Purified by ammonium sulfate precipitation.
Form
Supplied as a liquid in PBS, 0.52% sodium azide.
Specificity:
Recognizes human AADAC.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Saito,S., et.al., J. Hum. Genet. 48(5), 249-270 (2003).